 |
RSS Feed: WARF News |
Invitrogen and WARF Sign License Agreement for Human Embryonic Stem Cells (May 8, 2008)
WARF Licenses Influenza Vaccine Technology to FluGen, Start-up Company Founded by UW-Madison Inventor Kawaoka (May 8, 2008)
Roche NimbleGen CEO Rose Speaks on Successful Exit Strategies for Start-up Companies at WARF's Gilson Series (Apr 24, 2008)
Association of University Technology Managers Honors WARF's Andrew Cohn (Mar 31, 2008)
View All News Articles
